<DOC>
	<DOC>NCT00688402</DOC>
	<brief_summary>The purpose of the study is to compare different formulations of AZD3355 in regard to possible adverse events such as sensations of numbness, tinglings and heat in the skin.</brief_summary>
	<brief_title>Study to Compare Different Formulations of AZD3355</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Lesogaberan</mesh_term>
	<criteria>Provision of written informed consent Female subjects with no childbearing potentials or using highly efficient contraceptive methods Clinically normal physical findings Clinically significant illness within 2 weeks prior to the first dose of investigational product History of clinically significant disease Use of prescribed medication during the 2 weeks before administration of the first dose of investigational product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Reflux Inhibitor</keyword>
	<keyword>GERD</keyword>
	<keyword>formulations</keyword>
</DOC>